839.85MMarket Cap-4595P/E (TTM)
11.170High9.950Low7.02MVolume10.270Open10.060Pre Close75.70MTurnover13.01%Turnover RatioLossP/E (Static)77.76MShares24.17052wk High1.98P/B582.34MFloat Cap9.06052wk Low--Dividend TTM53.92MShs Float43.000Historical High--Div YieldTTM12.13%Amplitude2.500Historical Low10.787Avg Price1Lot Size
Kura Oncology Stock Forum
Kura Oncology Announces Publication of Ziftomenib Phase 1 Results in The Lancet Oncology | KURA Stock News
$Kura Oncology (KURA.US)$
No comment yet